Entire Agreement Vzorová ustanovení

Entire Agreement. 14.1 This Agreement constitutes the entire agreement between the Parties with respect to the subject-matter hereof and supersedes and replaces any prior proposals, negotiations, agreements and other written or oral communications between the Parties relating to the subject-matter hereof.
Entire Agreement. 13.1 Any Schedule attached to this agreement shall form an integral part of this Agreement.
Entire Agreement. This Agreement constitutes the entire agreement of the Parties and supersedes all prior communications, understandings and agreements relating to the subject matter hereof, whether oral or written.
Entire Agreement. This Agreement sets forth the entire agreement between Buyer and Bio-Rad with respect to the subject matter hereof and supersedes any and all prior and contemporaneous writings, communications, agreements and understandings relating to the same subject matter. Bio-Rad reserves the right to change these terms at any time. The version date for these terms may be found at the footer of this page.
Entire Agreement. This Agreement contains the entire understanding of the Parties with respect to the subject matter contained herein and supersedes any previous agreements on this subject matter executed by these Parties. No modification of this Agreement shall be effective unless the modification is in writing and signed by an authorised representative of each Party.
Entire Agreement. This Agreement, including all exhibits hereto, contains the entire understanding of the parties with respect to the subject matter herein and supersedes all previous agreements and undertakings with respect thereto. None of this Agreement or any of its terms, including any attachment or exhibit hereto, may be amended, restated or otherwise altered except by written agreement signed by the parties. The Czech language version of this Agreement shall govern all disputes hereunder. This Agreement has been made in 2 counterparts, each valid as original, each of parties obtaining one counterpart.
Entire Agreement. This Agreement, including its schedules, constitutes the entire agreement between Amgen and Buyer with respect to the subject matter of this Agreement and supersedes all earlier agreements and understandings (whether oral or written), between Amgen and Buyer and all earlier representations by any party about such smluvní strany o tomto předmětu. S úmyslem být právně vázány nechaly smluvní strany tuto Smlouvu podepsat svými řádně zmocněnými zástupci k výše uvedenému datu. subject matter. Intending to be legally bound, the parties have caused this Agreement to be executed by their duly authorized representatives as of the date set forth above. Podpis / By: Podpis / By: Jméno hůlkovým písmem / Printed Name: Jméno hůlkovým písmem/ Printed Name: Xxxxx Xxxxxx Xxxx Xxxxxx Xxxxxxxx Funkce / Title: Funkce / Title: Jednatel Jednatel Podpis / By: Jméno hůlkovým písmem / Printed Name: Xxx. Xxxxxxxxx Xxxxxx XXXx. Xxxx Xxxxxxx Funkce / Title: Člen představenstva PŘÍLOHA Č. 1 Přípravky Aranesp ® NEUPOGEN ® Neulasta ® Nplate ® Vectibix ® Prolia ® Kyprolis ® Repatha ® Mimpara ® XGEVA ® BLINCYTO ® IMLYGIC ® SCHEDULE 1 Products Aranesp ® NEUPOGEN ® Neulasta ® Nplate ® Vectibix ® Prolia ® Kyprolis ® Repatha ® Mimpara ® XGEVA ® BLINCYTO ® IMLYGIC ® Plán bonusů: / Bonus scheme: V případě, že je povinné snížení ceny dáno oficiálním snížením maximální ceny nebo úhrady, jak ji publikuje Státní úřad pro kontrolu léčiv, upravuje se bonus podle toho tak, aby se zachovala původní hladina In case there is a mandatory price cut driven by official decrease in maximum price or reimbursement published by State Institute of Drug Control, the bonus will be adjusted accordingly in order to preserve the original koncové čisté ceny. Bonus se poskytuje ve formě opravného daňového dokladu, který bude vystaven do třiceti dnů po úhradě všech faktur vztahujících se k příslušnému období (čtvrtletí). level of final net price. Bonus will be provided in a form of a credit note, which will be issued within 30 days after all invoices related to the respective period (the quarter) are paid. Price List valid from 1.1.2017 / Ceník platný od 1.1.2017 149770 Neulasta 6 mg 19 086,70 Kč 14902 Neupogen 300 mcg/1ml 4 122,76 Kč 78914 Neupogen 30 MU/0,5 ml 4 122,76 Kč 78906 Neupogen 48 MU/0,5 ml 6 596,42 Kč 28309 Mimpara 30 mg 3 600,00 Kč 28314 Mimpara 60 mg 7 207,37 Kč 28317 Mimpara 90 mg 10 908,00 Kč 167653 Prolia 60 mg/ml 4 427,38 Kč 26415 Aranesp 10 mcg blister 337,80 Kč 149579 Aranesp 20 mcg 675,60 Kč 149581 Ar...
Entire Agreement. No subsequent agreement, arrangement, relationship or understanding between the parties shall be valid, effective or enforceable and no obligation or liability shall be created on behalf of either party hereto unless and until it is contained in writing, signed by a duly authorised representatives of each party. The Agreement constitutes the entire understanding between the Seller and the Customer with respect to the subject matter, and supersedes and replaces all prior and contemporaneous agreements, whether written or oral, as to such subject matter.
Entire Agreement. The Agreement constitutes the entire agreement between the parties relating to the subject matter hereof. The Agreement supersedes any and all prior discussions and/or representations, whether written or oral, relating to the subject matter of the Agreement and no reference to prior dealings may be used to in any way modify the expressed understandings of the Agreement. Intergraph does not accept any contradictory or additional terms and conditions, even by accepting a purchase order referencing different terms and conditions. The Agreement may be amended only by a written instrument signed by authorized representatives of both parties, and cannot be amended by subsequent purchase order or writing received from Customer without the express written consent of Intergraph. Any reproduction of the Agreement made by reliable means (for example, photocopy or facsimile) will be deemed an original. 21.2
Entire Agreement. The following sentence is added at the beginning of this Section 19: